STING agonist-22 structure
|
Common Name | STING agonist-22 | ||
---|---|---|---|---|
CAS Number | 2408723-12-4 | Molecular Weight | 820.90 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C40H48N14O6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of STING agonist-22STING agonist-22 (CF501) is a potent non-nucleotide STING agonist. STING agonist-22 is a adjuvant by activating STING to induce the type I interferon (IFN-I) response and proinflammatory cytokine production. STING agonist-22 can be used as an adjuvant to boost the original protein vaccine, producing potent, broad, and long-term immune protection. STING agonist-22 can be used for SARS-CoV-2 variants and sarbecovirus diseases research[1]. |
Name | STING agonist-22 |
---|
Description | STING agonist-22 (CF501) is a potent non-nucleotide STING agonist. STING agonist-22 is a adjuvant by activating STING to induce the type I interferon (IFN-I) response and proinflammatory cytokine production. STING agonist-22 can be used as an adjuvant to boost the original protein vaccine, producing potent, broad, and long-term immune protection. STING agonist-22 can be used for SARS-CoV-2 variants and sarbecovirus diseases research[1]. |
---|---|
Related Catalog | |
In Vitro | STING agonist-22 (CF501) 导致 THP-1 细胞中先天免疫反应的快速和强烈激活[1]。 |
In Vivo | STING agonist-22 (CF501) 以可接受的安全性在小鼠中稳健但短暂地激活先天免疫[1]。 Animal Model: Balb/c mice (female, six weeks old)[1] Dosage: 20, 75 μg Administration: Intramuscular injection Result: Although innate immunity was activated only transiently by CF501, it should be sufficient to stimulate the required humoral and cellular immune responses. The half-life of CF501 was 0.5 h and there was no detectable CF501 in the plasma after 2 h of the injection. |
References |
Molecular Formula | C40H48N14O6 |
---|---|
Molecular Weight | 820.90 |